Laws & Regulations

Will New Medicaid Work Requirements Lead to Coverage Loss?
Infrastructure & Management Will New Medicaid Work Requirements Lead to Coverage Loss?

The recent overhaul of the Medicaid landscape represents one of the most significant shifts in public health policy in decades, effectively altering the fundamental contract between the government and millions of its most vulnerable citizens. Under the new guidelines introduced by the Centers for

Can Data Analytics Transform Employer-Led Healthcare?
Digital Health Can Data Analytics Transform Employer-Led Healthcare?

For decades, American businesses have been forced to navigate a labyrinthine healthcare system where they pay billions of dollars for services without ever truly understanding the quality or the underlying costs of the care their employees receive. To address this fundamental market failure,

Is Your Health Data Safe With Generative AI Chatbots?
Regulatory & Compliance Is Your Health Data Safe With Generative AI Chatbots?

The rapid adoption of generative artificial intelligence has fundamentally altered how individuals seek medical clarity, with millions now bypassing traditional search engines to engage in deep, descriptive dialogues with chatbots regarding their most private health concerns. This shift is

J&J Recalls Impella Heart Pumps Over Fatal Design Flaw
Infrastructure & Management J&J Recalls Impella Heart Pumps Over Fatal Design Flaw

When a multi-billion dollar acquisition meant to revolutionize cardiac care encounters a fatal mechanical defect, the ripple effects extend far beyond the hospital room into the very foundations of medical technology trust and regulatory oversight. The medical technology sector is currently

How Will the FTC Impact Ascension’s $3.9 Billion Merger?
Digital Health How Will the FTC Impact Ascension’s $3.9 Billion Merger?

The proposed acquisition of several key regional health systems by Ascension has triggered a massive federal review that could reshape the competitive landscape of the American healthcare industry for the next decade. As the Federal Trade Commission scrutinizes the $3.9 billion deal, the stakes

Olympus Colonoscopes Face FDA Bans and Superbug Lawsuits
Infrastructure & Management Olympus Colonoscopes Face FDA Bans and Superbug Lawsuits

The American healthcare system relies fundamentally on the colonoscopy as the primary diagnostic tool for the early detection and prevention of colorectal cancer, yet the safety of this routine procedure is currently under unprecedented scrutiny. At the heart of this intensifying controversy is the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later